Gamma Investing LLC Amicus Therapeutics, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 20 shares of FOLD stock, worth $139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 912
97.81%
Holding current value
$139
Previous $7.44 Million
98.45%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding FOLD
# of Institutions
313Shares Held
329MCall Options Held
437KPut Options Held
450K-
Vanguard Group Inc Valley Forge, PA29.4MShares$205 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.2MShares$204 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$170 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$150 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$143 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.96B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...